Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed asymmetric synthesis for spirobarbituric acid-epoxyhexane intermediates. High yield, mild conditions, and scalable supply chain solutions for pharma.
Patent CN108440542B details asymmetric synthesis of spiro oxindoles. High purity and mild conditions offer cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101679213A details organocatalytic routes for Aliskiren intermediates, offering cost-effective and scalable manufacturing solutions for pharmaceutical supply chains.
Novel organophosphine-catalyzed asymmetric [4+2] cycloaddition for high-purity chiral 3,4-dihydroquinazolin-2-ones. Scalable route with excellent enantioselectivity up to 92% ee.
Discover novel pyrroline chiral bisphosphine ligands from patent CN110041365B. High enantioselectivity synthesis for reliable pharmaceutical intermediate supply chains.
Novel NHC-Cu catalyzed route for Duloxetine intermediate offers high yield and purity. Cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN104592243B details a novel Sc(OTf)3 catalyzed route for Galantamine. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.
Novel copper-catalyzed desymmetrization method for high-purity chiral phosphine oxides. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply chain solutions.
Patent CN101569864B details a novel chiral sulfonamide catalyst enabling high-yield asymmetric conjugate addition, offering a metal-free alternative for pharmaceutical manufacturing.
Advanced patent CN104860975B enables cost-effective bortezomib intermediate production. Enhanced yield and purity for reliable pharmaceutical supply chains.
Advanced 4-step synthesis of Shikimic Acid from crotonaldehyde. Patent CN102633629B offers high purity >98% ee, reduced waste, and reliable supply chain solutions.
Patent CN112552184B reveals a scalable 4-step synthesis for cyclopropyl chiral amines, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN103429567A details a mild Rh-catalyzed process for chiral amino acids with >98% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN106146448A reveals efficient synthesis of chiral alpha-fluoro beta-amino ketones. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN105732550B reveals Pd-catalyzed synthesis enabling high-purity chiral dihydrofuran intermediates with significant supply chain and cost advantages.
Patent CN110862325B reveals a novel asymmetric cycloaddition route for high-purity Bictegravir intermediates, offering significant cost reduction and supply chain reliability.
Patent CN101717347B details a high-yield chemical route for L-theanine using BPB-Ni(II) complexes, offering superior optical purity and scalable production for global supply chains.
Patent CN106478567A reveals copper-catalyzed route for high-purity pharmaceutical intermediates offering significant supply chain advantages and cost reduction potential.
Patent CN102976995B reveals a novel organocatalytic route for pyrrolysine. Achieve high enantioselectivity and cost reduction in amino acid manufacturing with scalable methods.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.